Acuren is trading 4.2% down at $8.52, with no clear company-specific catalyst identified in available coverage.

  • Broader stocks are also under pressure on September 28, weighed down by rising oil prices and Treasury yields after President Trump rejected an Iranian peace proposal.
  • This macro backdrop may be contributing to Acuren’s decline, but available evidence does not confirm a direct link.